Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.
about
Striving for optimal bronchodilation: focus on olodaterolPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDA review of nebulized drug delivery in COPDEfficacy of tiotropium-olodaterol fixed-dose combination in COPDImpact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic FibrosisAssessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials.Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.Tiotropium/Olodaterol: A Review in COPD.Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD.Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease.Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease.The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Olodaterol + tiotropium bromide for the treatment of COPD.What Does the TOVITO Programme Tell Us about How We Can Manage COPD?
P2860
Q26752887-23C43906-E0DF-43A8-A634-19B211372835Q26778685-A02ACAD6-C82B-4287-AC70-31C6FE96C8FEQ28075295-C5365342-71D8-4D93-B816-F9BC2035A4AEQ28075367-5E060D8F-CFF0-456F-A605-CF0589B8A013Q36063173-3C50F6DE-A06B-490C-BC40-FE94A85F1196Q37447593-F8DD6080-73E4-4689-A2B3-6A07CD96D529Q37578975-F4A0D18D-C73C-4AB0-B2AC-2D515AB32E71Q38570714-21B9F788-8196-45C3-972E-6B18CC417E4CQ38673383-1595997E-4792-4221-9502-5D6644BF13A9Q38844053-CF381CF3-6C33-4452-90A4-A1FB99E297DDQ39674585-1139CEB5-D785-4C06-BF09-E5D2D4C7E4E5Q40878292-1E0B17CA-0B59-4D4E-BE77-3CBCC02C5220Q42944491-FB116EF6-2772-4EF8-B65B-6B5B7FA334EFQ47159721-F8BCE599-302F-46C3-8058-C6665799B20EQ47375559-85046DF3-A10B-403B-9E34-ACAE4F280FF7Q47657304-69A3CA63-0E49-4437-A75E-7C99B80F4D8BQ47661714-26449316-4656-45AE-8EAB-8004006F0163Q51545895-35EBCCBF-5C03-4C85-AACB-A05EFAAB0A52Q59131559-3B854749-1351-4483-BD3E-A084DCC057A6
P2860
Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@ast
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@en
type
label
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@ast
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@en
prefLabel
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@ast
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@en
P2093
P2860
P1433
P1476
Efficacy of Tiotropium + Oloda ...... ntensity: A Post Hoc Analysis.
@en
P2093
Gary T Ferguson
Lars Grönke
Lawrence Korducki
Matjaž Fležar
Roger Abrahams
Roland Buhl
Stephanie Korn
P2860
P2888
P304
P356
10.1007/S12325-015-0218-0
P407
P577
2015-06-26T00:00:00Z